International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thrombosis and haemostasis Ročník 118; číslo 3; s. 437 - 450
Hlavní autoři: Gosselin, Robert C., Adcock, Dorothy M., Bates, Shannon M., Douxfils, Jonathan, Favaloro, Emmanuel J., Gouin-Thibault, Isabelle, Guillermo, Cecilia, Kawai, Yohko, Lindhoff-Last, Edelgard, Kitchen, Steve
Médium: Journal Article
Jazyk:angličtina
Vydáno: Stuttgart Schattauer GmbH 01.03.2018
Témata:
Administration, Oral
Anticoagulants - analysis
Chromatography - standards
Clinical Laboratory Techniques - standards
Consensus Document
Dabigatran - analysis
Hematology - methods
Hematology - standards
Humans
International Cooperation
Mass Spectrometry - standards
Partial Thromboplastin Time
Point-of-Care Testing - standards
Prothrombin - analysis
Prothrombin Time
Pyrazoles - analysis
Pyridines - analysis
Pyridones - analysis
Quality Assurance, Health Care
Rivaroxaban - analysis
Thiazoles - analysis
direct oral anticoagulants
laboratory guidance
laboratory measurement
recommendations
ISSN:0340-6245, 2567-689X, 2567-689X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0340-6245
2567-689X
2567-689X
DOI:10.1055/s-0038-1627480